Diet Modifies Pioglitazone's Influence on Hepatic PPARγ-Regulated Mitochondrial Gene Expression

Pioglitazone (Pio) is a thiazolidinedione (TZD) insulin-sensitizing drug whose effects result predominantly from its modulation of the transcriptional activity of peroxisome proliferator-activated-receptor-gamma (PPARγ). Pio is used to treat human insulin-resistant diabetes and also frequently consi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulkarni, Sakil, Huang, Jiansheng, Tycksen, Eric, Cliften, Paul F., Rudnick, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501566/
https://www.ncbi.nlm.nih.gov/pubmed/32963510
http://dx.doi.org/10.1155/2020/3817573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501566/
https://www.ncbi.nlm.nih.gov/pubmed/32963510
http://dx.doi.org/10.1155/2020/3817573

Ejemplares similares